These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23419487)

  • 1. Without therapeutic drug monitoring, there is no personalized cancer care.
    Beumer JH
    Clin Pharmacol Ther; 2013 Mar; 93(3):228-30. PubMed ID: 23419487
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomicelles for advancing personalized therapy.
    Sawant RR; Jhaveri AM; Torchilin VP
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1436-46. PubMed ID: 22917778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted and personalized therapy for cancer: theory and practice in China.
    Liu Q; Zhang X; Zeng Y
    Sci China Life Sci; 2011 Dec; 54(12):1081-4. PubMed ID: 22227898
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor heterogeneity as the foundation of personalized cancer treatment.
    Schilsky RL
    Semin Oncol; 2011 Apr; 38(2):171-2. PubMed ID: 21421107
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personalized treatment of cancer: utopia or chance?].
    Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
    [No Abstract]   [Full Text] [Related]  

  • 7. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 8. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining clinical trials: the age of personalized medicine.
    Vaidyanathan G
    Cell; 2012 Mar; 148(6):1079-80. PubMed ID: 22424218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M
    Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of TDM, phenotyping and genotyping for the correct drug dosage].
    Grundmann M; Kacírová I
    Cas Lek Cesk; 2010; 149(10):482-7. PubMed ID: 21121139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B
    Cancer Cytopathol; 2012 Oct; 120(5):283-4. PubMed ID: 23065928
    [No Abstract]   [Full Text] [Related]  

  • 14. Bridging the gap: cytopathology at the threshold of personalized medicine.
    Layfield LJ; Bedrossian CW
    Diagn Cytopathol; 2012 Jun; 40(6):469-71. PubMed ID: 22619122
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis for cancer treatment decisions.
    Dancey JE; Bedard PL; Onetto N; Hudson TJ
    Cell; 2012 Feb; 148(3):409-20. PubMed ID: 22304912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A; Jackson DB
    Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling and personalized medicine: from the guest editor.
    Chu E
    Cancer J; 2011; 17(2):69-70. PubMed ID: 21427549
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.